Skip to content
DataLookout
Menu

NCT04141592

Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Jul 31, 2026 to Jul 31, 2027
    • Eligibility criteria expanded, about 12 words
    • Collaborators: details revised at 2 of 3 entries
  2. Minor Primary and study completion dates: Apr 1, 2026 to Jul 31, 2026v6
  3. Notable Primary and study completion dates: Apr 1, 2025 to Apr 1, 2026v5
  4. Notable Primary and study completion dates pushed to Apr 1, 2025
    • Start date: Feb 19, 2019 to Mar 5, 2019
    v4
  5. Notable Primary completion date: Feb 5, 2023 to Sep 5, 2023
    • Study completion date: Sep 5, 2023 to Dec 29, 2023
    • Study arms: 4 to 3
    v3
  6. Notable Primary completion date: Sep 5, 2020 to Feb 5, 2023
    • Study completion date: Sep 5, 2020 to Sep 5, 2023
    v2
  7. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Impact of weight loss surgery upon Non-alcoholic steatohepatitis
Timeframe: Two years

Secondary (1)

Impact of weight loss surgery upon Non-invasive measures of fibrosis

Arms and interventions

Healthy Control

non-obese individuals without fatty liver disease

Obese wihtout non-alcoholic steatohepatitis

Body mass index greater than 30 without liver histological evidence of non-alcoholic fatty liver disease

Obese Non-alcoholic steatohepatitis

Body mass index greater than 30 with liver histological evidence of non-alcoholic fatty liver disease

Procedures: Bariatric Surgery

Sites

1 site in 1 country

  • Homerton University Hospital Foundation TrustLondon, Greater London, United Kingdom